Bhandari Medicals Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 10-12-2024
- Paid Up Capital ₹ 0.31 M
as on 10-12-2024
- Company Age 31 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.59 M
as on 10-12-2024
- Revenue -6.83%
(FY 2023)
- Profit -877.78%
(FY 2023)
- Ebitda -15.61%
(FY 2023)
- Net Worth -6.02%
(FY 2023)
- Total Assets 2.43%
(FY 2023)
About Bhandari Medicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.31 M.
The company currently has active open charges totaling ₹1.59 M.
Sudhir Bhandari, Sandeep Bhandari, and Videsh Bhandari serve as directors at the Company.
- CIN/LLPIN
U24232RJ1993PTC007592
- Company No.
007592
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationN.G.H.Road,Jodhpur, Rajasthan
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bhandari Medicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Bhandari  | Director | 01-Apr-1998 | Current |
| Sandeep Bhandari | Director | 25-Jun-2019 | Current |
| Videsh Bhandari | Director | 01-Nov-2012 | Current |
Financial Performance of Bhandari Medicals.
Bhandari Medicals Pvt. Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.83% decrease. The company also saw a substantial fall in profitability, with a 877.78% decrease in profit. The company's net worth dipped by a decrease of 6.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhandari Medicals?
Unlock access to Bhandari Medicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Dec 2021 | ₹0.10 M | Open |
Bank Of India Creation Date: 11 Oct 2021 | ₹1.24 M | Open |
State Bank Of Bikaner And Jaipur Creation Date: 17 Nov 2007 | ₹0.25 M | Open |
How Many Employees Work at Bhandari Medicals?
Bhandari Medicals has a workforce of 7 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhandari Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhandari Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
